Bristol-Myers Squibb

NYSE: BMY · Real-Time Price · USD
48.47
0.66 (1.38%)
At close: Aug 15, 2025, 3:59 PM
48.50
0.07%
After-hours: Aug 15, 2025, 07:00 PM EDT

Bristol-Myers Squibb Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-8.93B 8.04B 6.34B 7.01B
Depreciation & Amortization
9.6B 9.76B 10.28B 10.69B
Stock-Based Compensation
507M 518M 457M 583M
Other Working Capital
848M -366M -1.61B -465M
Other Non-Cash Items
15.29B 744M 955M 578M
Deferred Income Tax
-2.09B -3.29B -2.74B -1.39B
Change in Working Capital
810M -1.91B -2.23B -1.26B
Operating Cash Flow
15.19B 13.86B 13.07B 16.21B
Capital Expenditures
-1.25B -1.21B -1.12B -973M
Cash Acquisitions
-20.72B -260M -2.98B -862M
Purchase of Investments
-769M -1.77B -3.59B -5.48B
Sales Maturities Of Investments
1.39B 948M 6.63B 6.78B
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-21.35B -2.29B -1.06B -538M
Debt Repayment
10.1B 456M -5.31B -6.18B
Common Stock Repurchased
n/a -5.16B -8B -6.29B
Dividend Paid
-4.86B -4.74B -4.63B -4.4B
Other Financial Acitivies
-106M 27M 984M 641M
Financial Cash Flow
5.13B -9.42B -16.96B -16.22B
Net Cash Flow
-1.17B 2.19B -4.99B -657M
Free Cash Flow
13.94B 12.65B 11.95B 15.23B